Specific modification of carriers to achieve targeted transport of chemotherapeutics into malignant tumors is critical for tumor theranosis [1].Among the tumor targeted strategies,the combination of antibody and nanoparticles can improve the specificity of nanoparticles and,in turn,reduce the immunogenicity of antibody [2].